Patients with precancerous gastric lesions present several circulating serum glycoproteins carrying abnormal O-glycans (e.g., plasminogen, vitronectin, and IGH protein), candidate targets for the non-invasive diagnosis of precursor GC lesions [135]. Here, PLG is linked to gastric cancer.